DrugPatentWatch Database Preview
Nexgen Pharma Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?
NEXGEN PHARMA INC has seventeen approved drugs.
Summary for Nexgen Pharma Inc
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 17 |
Drugs and US Patents for Nexgen Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexgen Pharma Inc | NABUMETONE | nabumetone | TABLET;ORAL | 203166-002 | Aug 30, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Nexgen Pharma Inc | BROMPHENIRAMINE MALEATE | brompheniramine maleate | TABLET;ORAL | 086187-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Nexgen Pharma Inc | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 209587-001 | Oct 31, 2018 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Nexgen Pharma Inc | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET, CHEWABLE;ORAL | 086392-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
